Author name: Leonardo Arias

A judge dismissed several claims brought by startup Particle Health against the EHR giant, but allowed some federal allegations to continue in court. 

Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named  a new CEO, and PFA pioneer Steven Mickelsen has launched another company.

After receiving a complete response letter for its pyruvate dehydrogenase complex deficiency candidate, Saol Therapeutics anticipates it will need “several years” and “significant financial resources” to address the FDA’s concerns.

The findings throw cold water on allegations from hospital groups that MA plans contribute to shrinking margins.

Regeneron’s antibody duos significantly lowered eye itching and redness, as well as pin prick reactivity, in people with cat and birch allergies. Still, BMO Capital Markets expressed uncertainty about the assets’ “commercial potential in a highly generic market.”

Novartis has been investing heavily in its cardiovascular pipeline this year, forging partnerships with Flagship startup ProFound Therapeutics and China’s Argo Biopharmaceutical, among others.

If LB is successful, the debut would mark the first IPO in months for the sector, as the biotech industry continues to endure a nuclear winter.

Truist Securities called pumitamig’s data on Monday “very reassuring,” given the consistency between its performance in Chinese and global patient populations.

El cáncer de células renales, también llamado cáncer de riñón, es una enfermedad que se origina en el revestimiento de los túbulos del riñón. Aunque se trata de una patología poco frecuente (responsable de entre el 2 y el 3 por ci …

Unos científicos han creado un nuevo material al combinar compuestos organometálicos con celulosa. El resultado es una sustancia porosa que se activa con la luz solar y que se aplica sobre las heridas, como una especie de tirita, para reducir el crecimiento bacteriano.   El logr …